Application of response surface methodology to maximize the productivity of scalable automated human embryonic stem cell manufacture

Written by Regenerative Medicine

In this preliminary communication, published in Regenerative Medicine, learn more about an automated ‘quality-by-design’ approach for scalable production of human embryonic stem cells. This article has been made free exclusively for members of RegMedNet. Large quantities of high-quality human cells are necessary for commercial, wide-spread provision of many regenerative and advanced therapies. However, the cost and complexity in manufacturing cell therapies can be prohibitive. Could an automated, ‘quality-by-design’ approach be the answer? Want to learn more about the production of embryonic stem cells? Check out our feature, now live>> In this preliminary communication, published in Regenerative Medicine, a team from the Healthcare Engineering...

To view the full article, please register now for access

It's completely free